Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanne H Tonino

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|June 10, 2010
Standards for the treatment of relapsed chronic lymphocytic leukemia: a case-based studyArnon P Kater, Sanne H Tonino
Blood|February 8, 2024
The quest for a cure in follicular lymphomaSanne H Tonino, Marie José Kersten
Expert Review of Hematology|June 21, 2018
Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendationsTim R De Back, Arnon P Kater, Sanne H Tonino
International Journal of Molecular Sciences|September 6, 2019
Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic LeukemiaTom Hofland, Eric Eldering, Arnon P Kater, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2021
How to choose first salvage therapy in Hodgkin lymphoma: traditional chemotherapy vs novel agentsJulia Driessen, Sanne H Tonino, Alison J Moskowitz, et al.
Blood|August 28, 2014
How does lenalidomide target the chronic lymphocytic leukemia microenvironment?Arnon P Kater, Sanne H Tonino, Alexander Egle, et al.
Cancers|October 13, 2021
Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. <i>Cancers</i> 2020, <i>12</i>, 3837Jaco A C van Bruggen, Anne W J Martens, Sanne H Tonino, et al.
Current Opinion in Oncology|June 13, 2025
Perspectives on T-cell engaging therapies in relapsed/refractory indolent non-Hodgkin lymphomaMax Bakker, Maria T Kuipers, Marie Jose Kersten, et al.
Cancers|December 23, 2020
Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin LymphomaJaco A C van Bruggen, Anne W J Martens, Sanne H Tonino, et al.
Blood|June 4, 2008
No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemiaSanne H Tonino, Rene Spijker, Dieuwertje M P Luijks, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical Lymphoma, Myeloma & Leukemia|June 10, 2010
Standards for the treatment of relapsed chronic lymphocytic leukemia: a case-based studyArnon P Kater, Sanne H Tonino
Blood|February 8, 2024
The quest for a cure in follicular lymphomaSanne H Tonino, Marie José Kersten
Expert Review of Hematology|June 21, 2018
Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendationsTim R De Back, Arnon P Kater, Sanne H Tonino
International Journal of Molecular Sciences|September 6, 2019
Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic LeukemiaTom Hofland, Eric Eldering, Arnon P Kater, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2021
How to choose first salvage therapy in Hodgkin lymphoma: traditional chemotherapy vs novel agentsJulia Driessen, Sanne H Tonino, Alison J Moskowitz, et al.
Blood|August 28, 2014
How does lenalidomide target the chronic lymphocytic leukemia microenvironment?Arnon P Kater, Sanne H Tonino, Alexander Egle, et al.
Cancers|October 13, 2021
Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. <i>Cancers</i> 2020, <i>12</i>, 3837Jaco A C van Bruggen, Anne W J Martens, Sanne H Tonino, et al.
Current Opinion in Oncology|June 13, 2025
Perspectives on T-cell engaging therapies in relapsed/refractory indolent non-Hodgkin lymphomaMax Bakker, Maria T Kuipers, Marie Jose Kersten, et al.
Cancers|December 23, 2020
Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin LymphomaJaco A C van Bruggen, Anne W J Martens, Sanne H Tonino, et al.
Blood|June 4, 2008
No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemiaSanne H Tonino, Rene Spijker, Dieuwertje M P Luijks, et al.
Pageof 5